Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Advisors
Partners
Careers
Technology
NETs Platform
SubB2M Platform
hTERT ICC Assay
Intellectual Property
Publications & Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
EXO-OC™ Ovarian Cancer Screening Test
Exosome Therapeutics
NeuCA15-3 Test
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2026
2025
2024
2023
2022
2021
2020
15-Jul-2026
Change of Director's Interest Notice
14-Jul-2026
EXO-OC Study Outcome Investor Webinar Presentation
13-Jul-2026
Quarterly Activities Report and Appendix 4C - June 2026
8-Jul-2026
Investor Briefing on EXO-OC Test and study outcome
1-Jul-2026
EXO-OC algorithm and clinical study update
29-Jun-2026
Trading Halt
25-Jun-2026
Positive CAR-exosome data in ovarian cancer
26-May-2026
Change of Director's Interest Notice - Peter Gunzburg
22-May-2026
Change of Director's Interest Notice - Peter Gunzburg
19-May-2026
Change of Director's Interest Notice - Peter Gunzburg
1
2
Next
